ChemoCentryx
CCXI
#3670
Rank
NZ$6.69 B
Marketcap
NZ$93.11
Share price
0.00%
Change (1 day)
34.76%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): NZ-$2.81

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is NZ-$3.38. In 2021 the company made an earnings per share (EPS) of NZ-$3.38 a decrease over its 2020 EPS that were of NZ-$1.45.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$2.81-16.94%
2021NZ-$3.38133.33%
2020NZ-$1.45-16.49%
2019NZ-$1.7427.63%
2018NZ-$1.36-305.41%
2017NZ$0.66-142.53%
2016NZ-$1.56-19.44%
2015NZ-$1.93-0%
2014NZ-$1.9313.68%
2013NZ-$1.70-16.67%
2012NZ-$2.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.97-453.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.36-140.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$6.39-288.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$29.05-958.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$4.23-224.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.78-152.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.10-339.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.15-252.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.13-133.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel